Theranica’s Post

Childhood and adolescent migraine: A growing concern with lifelong implications. Migraine isn’t just a debilitating disease that affects adults, it also impacts 1 in 10 children.[1] The burden on young people is also alarming, as migraine disease affects their overall quality of life.[2] Early intervention is critical. If left untreated, migraine that starts in childhood often worsens into adulthood, increasing the likelihood of chronic migraine.[3] That’s where the Nerivio® REN wearable comes in. As the only FDA-cleared, drug-free acute and preventive migraine treatment for ages 8+, the Nerivio REN wearable can serve as a first-line therapy for children and adolescents living with migraine. It empowers young patients to take an active role in managing their migraine disease. Together, we can improve outcomes and help children and adolescents thrive without the weight of debilitating migraine attacks. Learn more about how the REN wearable can help children as young as 8 years old manage their migraine symptoms at nerivio.com —----------------------------------------- 1. Khalil et al, “Migraine Headache in Childhood”, 2023.  2. Chen et al, “Global, regional, and national burden and trends of migraine among youths and young adults aged 15–39 years from 1990 to 2021: findings from the global burden of disease study 2021”, 2024.  3. Gazerani, Parisa “Migraine and Mood in Children”, 2021.

To view or add a comment, sign in

Explore topics